These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8584782)

  • 1. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure].
    Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E
    Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant hyperthermia during desflurane-succinylcholine anesthesia for orthopedic surgery.
    Garrido S; Fraga M; Martín MJ; Belda J
    Anesthesiology; 1999 Apr; 90(4):1208-9. PubMed ID: 10201695
    [No Abstract]   [Full Text] [Related]  

  • 3. No response to trigger agents in a malignant hyperthermia-susceptible patient.
    Claxton BA; Cross MH; Hopkins PM
    Br J Anaesth; 2002 Jun; 88(6):870-3. PubMed ID: 12173209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical malignant hyperthermia. A higher incidence than expected].
    Herrero E; Casinello F; de Stefano J; Fernández-Guisasola J; Pérez-Gallardo A
    Rev Esp Anestesiol Reanim; 1996 Jan; 43(1):42-3. PubMed ID: 8851836
    [No Abstract]   [Full Text] [Related]  

  • 5. Duchenne muscular dystrophy: Which is the best anesthetic agent?
    Driessen J; Snoeck M
    Paediatr Anaesth; 2008 Oct; 18(10):1007-8. PubMed ID: 18811853
    [No Abstract]   [Full Text] [Related]  

  • 6. Human malignant hyperthermia associated with desflurane anesthesia.
    Allen GC; Brubaker CL
    Anesth Analg; 1998 Jun; 86(6):1328-31. PubMed ID: 9620529
    [No Abstract]   [Full Text] [Related]  

  • 7. Suxamethonium, masseter spasm and later malignant hyperthermia.
    Ramirez JA; Cheetham ED; Laurence AS; Hopkins PM
    Anaesthesia; 1998 Nov; 53(11):1111-6. PubMed ID: 10023282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
    Hogan KJ; Vladutiu GD
    Anesth Analg; 2009 Oct; 109(4):1070-2. PubMed ID: 19762733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal malignant hyperthermia--delayed onset and atypical course.
    Karger B; Teige K
    Forensic Sci Int; 2002 Oct; 129(3):187-90. PubMed ID: 12372688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hyperthermia induced by general anesthesia for bone marrow harvesting.
    Hosoya N; Miyagawa K; Mimura T; Hoshide S; Akazawa H; Kanda Y; Takahashi N; Hirai H; Maekawa K; Yazaki Y
    Bone Marrow Transplant; 1997 Mar; 19(5):509-11. PubMed ID: 9052921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia.
    Dexter F; Epstein RH; Wachtel RE; Rosenberg H
    Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder.
    Flick RP; Gleich SJ; Herr MM; Wedel DJ
    Paediatr Anaesth; 2007 Jan; 17(1):22-7. PubMed ID: 17184427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anesthesia in hereditary peripheral muscular disease].
    Islander G; Jungner M
    Lakartidningen; 2005 Feb 21-27; 102(8):566-71. PubMed ID: 15786909
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ENT anesthesia: the German Society of Anesthesia and Intensive Care Medicine on the use of succinylcholine].
    HNO; 1995 Nov; 43(11):640-1. PubMed ID: 8530309
    [No Abstract]   [Full Text] [Related]  

  • 16. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
    Brandom BW; Muldoon SM
    Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hyperthermia and muscular dystrophies.
    Gurnaney H; Brown A; Litman RS
    Anesth Analg; 2009 Oct; 109(4):1043-8. PubMed ID: 19762730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperthermia: a case report in Thai Anesthesia Incidents Study (THAI Study).
    Pulnitiporn A; Charuluxananan S; Inphum P; Kitsampanwong W
    J Med Assoc Thai; 2005 Nov; 88 Suppl 7():S149-52. PubMed ID: 16862689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volatile anesthetics and succinylcholine in cardiac ryanodine receptor defects.
    Swan H; Laitinen PJ; Toivonen L
    Anesth Analg; 2004 Aug; 99(2):435-7, table of contents. PubMed ID: 15271719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist?
    Driessen JJ
    Curr Opin Anaesthesiol; 2008 Jun; 21(3):350-5. PubMed ID: 18458553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.